IE00BM8R0N95
IE00BM8R0N95
Genomics & Biotechnology UCITS ETF
Loading chart...
Holdings & Portfolio Structure
Holdings as of 09/14/2026Detailed breakdown of ETF components
All Holdings
# | Ticker | Name | Sector | Industry | Market Cap | Weight | P/E | Fwd P/E | D/E | P/B | P/S | EV/EBITDA | P/FCF | FCF Yield | Revenue Estimate | EPS Estimate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Moderna, Inc. | Healthcare | Biotechnology | 80,17 Mrd. € | 7.96% | - | -50.70 | 19.04% | 13.28 | 40.32 | -34.08 | 300.18 | 0.33% | FY Cur +8.09% (21) Q Cur -12.17% (14) FY Next +16.07% (19) Q Next -24.31% (13) | FY Cur -15.53% (21) Q Cur -149.18% (15) FY Next +43.00% (20) Q Next -37.19% (14) | |
| 2 | 10x Genomics, Inc. | Healthcare | Medical Devices | 9,38 Mrd. € | 6.24% | - | 1051.91 | 9.54% | 12.73 | 17.03 | -232.90 | 58.49 | 1.71% | FY Cur -3.47% (17) Q Cur -0.79% (16) FY Next +9.72% (17) Q Next +16.00% (16) | FY Cur -70.21% (3) Q Cur +12.28% (2) FY Next +109.08% (3) Q Next +75.00% (2) | |
| 3 | Twist Bioscience Corporation | Healthcare | Biotechnology | 9,45 Mrd. € | 6.00% | - | -399.45 | 24.36% | 22.47 | 24.53 | -82.20 | - | -0.61% | FY Cur +21.18% (12) Q Cur +24.77% (11) FY Next +20.16% (11) Q Next +2.34% (8) | FY Cur +54.63% (4) Q Cur +67.26% (3) FY Next +58.32% (4) Q Next +6.33% (3) | |
| 4 | Guardant Health, Inc. | Healthcare | Diagnostics & Research | 20,06 Mrd. € | 5.39% | - | -405.82 | - | - | 19.00 | -53.09 | 844.66 | 0.12% | FY Cur +38.24% (25) Q Cur +32.20% (21) FY Next +35.29% (25) Q Next +5.32% (20) | FY Cur +19.43% (21) Q Cur +19.79% (17) FY Next +71.86% (19) Q Next +11.31% (17) | |
| 5 | Natera, Inc. | Healthcare | Diagnostics & Research | 51,55 Mrd. € | 4.87% | - | -2028.91 | 13.09% | 31.59 | 21.34 | -247.20 | 555.23 | 0.18% | FY Cur +26.17% (22) Q Cur +19.45% (20) FY Next +20.65% (22) Q Next +5.85% (18) | FY Cur +5.05% (16) Q Cur +58.50% (15) FY Next +86.32% (16) Q Next +60.98% (14) | |
| 6 | Illumina, Inc. | Healthcare | Diagnostics & Research | 37,49 Mrd. € | 4.84% | 51.90 | 45.46 | 89.04% | 14.80 | 9.35 | 35.77 | 52.66 | 1.90% | FY Cur +6.48% (19) Q Cur +6.34% (17) FY Next +6.46% (19) Q Next +5.84% (16) | FY Cur +10.69% (21) Q Cur +1.31% (19) FY Next +14.20% (21) Q Next +13.15% (18) | |
| 7 | Bio-Techne Corp | Healthcare | Biotechnology | 10,14 Mrd. € | 3.77% | 62.47 | 31.33 | 13.71% | 5.37 | 9.35 | 34.08 | 49.48 | 2.02% | FY Cur +4.35% (12) Q Cur +1.97% (8) FY Next +10.04% (9) Q Next +5.33% (7) | FY Cur +4.48% (11) Q Cur +6.92% (7) FY Next +14.69% (9) Q Next +7.19% (6) | |
| 8 | GENSCRIPT BIO | Healthcare | Biotechnology | 10,99 Mrd. € | 3.76% | - | 588.89 | 8.82% | 3.04 | 114.43 | 459.62 | 1019.39 | 0.10% | FY Cur -7.31% (6) Q Cur - (0) FY Next +20.79% (7) Q Next - (0) | FY Cur -71.46% (1) Q Cur - FY Next +140.00% (2) Q Next - | |
| 9 | BioMarin Pharmaceutical Inc. | Healthcare | Biotechnology | 9,47 Mrd. € | 3.73% | 148.09 | 8.26 | 66.47% | 1.68 | 3.11 | 21.62 | 124.56 | 0.80% | FY Cur +21.29% (24) Q Cur +32.03% (20) FY Next +14.48% (24) Q Next +9.79% (20) | FY Cur +49.09% (18) Q Cur +767.08% (14) FY Next +41.33% (18) Q Next +68.38% (15) | |
| 10 | Vertex Pharmaceuticals Incorpor | Healthcare | Biotechnology | 115,31 Mrd. € | 3.62% | 29.71 | 25.23 | 9.77% | 6.38 | 10.26 | 23.86 | 49.17 | 2.03% | FY Cur +10.45% (16) Q Cur +11.16% (13) FY Next +9.84% (16) Q Next +3.20% (14) | FY Cur -11.12% (16) Q Cur -115.38% (13) FY Next +23.62% (16) Q Next +721.48% (14) | |
| 11 | Arrowhead Pharmaceuticals, Inc. | Healthcare | Biotechnology | 7,89 Mrd. € | 3.44% | - | -12.73 | 295.98% | 19.03 | 13.20 | -41.68 | - | -0.55% | FY Cur -44.33% (15) Q Cur -77.18% (14) FY Next -27.60% (15) Q Next -21.82% (6) | FY Cur -35300.40% (14) Q Cur -752.98% (14) FY Next -39.29% (14) Q Next +11.01% (7) | |
| 12 | Qiagen N.V. | Healthcare | Diagnostics & Research | 8,36 Mrd. € | 3.26% | 23.04 | 17.37 | 49.25% | 2.79 | 4.46 | 13.70 | 25.13 | 3.98% | FY Cur +2.16% (17) Q Cur +0.38% (9) FY Next +5.06% (17) Q Next +7.17% (9) | FY Cur +2.28% (13) Q Cur -3.35% (9) FY Next +7.32% (13) Q Next +5.41% (9) | |
| 13 | Praxis Precision Medicines, Inc | Healthcare | Biotechnology | 6,48 Mrd. € | 3.05% | - | -27.85 | 0.08% | 5.41 | - | -17.46 | - | -2.75% | FY Cur +0.00% (18) Q Cur +0.00% (16) FY Next +39458.00% (18) Q Next - (18) | FY Cur -3.38% (17) Q Cur -8.09% (17) FY Next +33.03% (16) Q Next -15.92% (17) | |
| 14 | CRISPR Therapeutics AG | Healthcare | Biotechnology | 4,61 Mrd. € | 2.80% | - | -15.18 | 44.87% | 2.95 | 385.49 | -6.42 | - | -4.18% | FY Cur +204.90% (17) Q Cur +1760.02% (15) FY Next +283.48% (16) Q Next -1.10% (15) | FY Cur +31.18% (18) Q Cur +10.01% (17) FY Next +21.03% (18) Q Next -10.08% (17) | |
| 15 | BioNTech SE | Healthcare | Biotechnology | 21,74 Mrd. € | 2.74% | - | -19.82 | 1.78% | 1.22 | 9.19 | -7.23 | - | -1.02% | FY Cur -37.73% (18) Q Cur -29.90% (11) FY Next +0.51% (17) Q Next -52.56% (11) | FY Cur -896.28% (10) Q Cur +730.57% (5) FY Next -2.30% (10) Q Next -199.60% (5) | |
| 16 | Veracyte, Inc. | Healthcare | Diagnostics & Research | 3,25 Mrd. € | 2.54% | 32.31 | 23.25 | 2.89% | 2.62 | 6.47 | 26.96 | 34.23 | 2.92% | FY Cur +14.80% (13) Q Cur +11.59% (12) FY Next +10.94% (13) Q Next +6.89% (12) | FY Cur +7.43% (12) Q Cur -19.49% (12) FY Next +1.74% (12) Q Next +9.03% (12) | |
| 17 | Caris Life Sciences, Inc. | Healthcare | Biotechnology | 7,49 Mrd. € | 2.35% | 17.57 | 80.46 | 76.45% | 14.18 | 8.48 | 42.70 | 132.67 | 0.75% | FY Cur +26.75% (14) Q Cur +17.52% (13) FY Next +19.16% (14) Q Next +15.78% (13) | FY Cur +133.52% (11) Q Cur -72.33% (10) FY Next +170.41% (11) Q Next +394.63% (10) | |
| 18 | Legend Biotech Corporation | Healthcare | Biotechnology | 3,23 Mrd. € | 2.20% | - | 17.73 | 22.63% | 2.93 | 2.85 | -70.65 | 133.17 | 0.75% | FY Cur +39.25% (10) Q Cur +31.21% (9) FY Next +24.74% (10) Q Next +6.11% (9) | FY Cur +99.38% (1) Q Cur +104.55% (1) FY Next +6931.00% (2) Q Next +800.00% (1) | |
| 19 | uniQure N.V. | Healthcare | Biotechnology | 1,4 Mrd. € | 1.97% | - | -8.37 | 170.40% | 4.83 | 83.92 | -7.14 | - | -4.95% | FY Cur +56.20% (11) Q Cur +70.51% (9) FY Next +357.08% (10) Q Next +28.29% (9) | FY Cur -17.89% (10) Q Cur +30.67% (10) FY Next +21.80% (10) Q Next +1.51% (10) | |
| 20 | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 938,15 Mrd. € | 1.86% | 39.26 | 24.76 | 162.07% | 31.03 | 13.19 | 26.10 | 94.99 | 1.05% | FY Cur +35.78% (28) Q Cur +27.08% (14) FY Next +15.65% (28) Q Next +4.56% (15) | FY Cur +47.76% (27) Q Cur +15.31% (17) FY Next +33.16% (27) Q Next +24.20% (17) | |
| 21 | CareDx, Inc. | Healthcare | Diagnostics & Research | 2,94 Mrd. € | 1.85% | 30.61 | 49.36 | 4.52% | 7.70 | 7.19 | 230.33 | 29.37 | 3.41% | FY Cur +30.36% (7) Q Cur +21.89% (7) FY Next +6.23% (7) Q Next +1.27% (7) | FY Cur +106.61% (6) Q Cur -8.93% (6) FY Next +7.65% (6) Q Next -9.15% (6) | |
| 22 | Beam Therapeutics Inc. | Healthcare | Biotechnology | 2,37 Mrd. € | 1.79% | - | -5.42 | 23.17% | 2.41 | 17.01 | -4.36 | - | -9.11% | FY Cur -65.24% (14) Q Cur +2.70% (12) FY Next +29.19% (12) Q Next +16.18% (12) | FY Cur -449.82% (14) Q Cur -6.32% (13) FY Next -6.46% (12) Q Next -1.49% (13) | |
| 23 | GeneDx Holdings Corp. | Healthcare | Diagnostics & Research | 1,79 Mrd. € | 1.76% | - | 56.18 | 68.55% | 8.22 | 4.42 | -60.98 | - | -2.37% | FY Cur +12.70% (9) Q Cur +5.30% (8) FY Next +24.31% (8) Q Next +16.04% (8) | FY Cur -90.61% (7) Q Cur -85.13% (7) FY Next +811.95% (7) Q Next +339.20% (7) | |
| 24 | Gilead Sciences, Inc. | Healthcare | Drug Manufacturers - General | 167,29 Mrd. € | 1.68% | - | 15.24 | 223.47% | 15.86 | 6.15 | 13.95 | 19.19 | 5.21% | FY Cur +4.36% (25) Q Cur +0.17% (20) FY Next +6.57% (24) Q Next +4.63% (17) | FY Cur -105.06% (27) Q Cur -11.85% (22) FY Next +2503.59% (26) Q Next -0.10% (20) | |
| 25 | Sarepta Therapeutics, Inc. | Healthcare | Biotechnology | 1,68 Mrd. € | 1.64% | - | 7.41 | 69.54% | 1.23 | 0.95 | -125.33 | 85.16 | 1.17% | FY Cur -16.55% (20) Q Cur -11.87% (18) FY Next -24.87% (19) Q Next -0.34% (18) | FY Cur +185.61% (10) Q Cur +379.49% (10) FY Next -44.25% (10) Q Next -69.51% (10) |
Results: 50
Weight 7.96%
Market Cap €80.17B
P/E -
Fwd P/E -50.7
Weight 6.24%
Market Cap €9.38B
P/E -
Fwd P/E 1051.9
Weight 6.01%
Market Cap €9.45B
P/E -
Fwd P/E -399.4
Weight 5.39%
Market Cap €20.06B
P/E -
Fwd P/E -405.8
Weight 4.87%
Market Cap €51.55B
P/E -
Fwd P/E -2028.9
Weight 4.84%
Market Cap €37.49B
P/E 51.9
Fwd P/E 45.5
Weight 3.77%
Market Cap €10.14B
P/E 62.5
Fwd P/E 31.3
Weight 3.76%
Market Cap €10.99B
P/E -
Fwd P/E 588.9
Weight 3.73%
Market Cap €9.47B
P/E 148.1
Fwd P/E 8.3
Weight 3.62%
Market Cap €115.31B
P/E 29.7
Fwd P/E 25.2
Weight 3.44%
Market Cap €7.89B
P/E -
Fwd P/E -12.7
Weight 3.26%
Market Cap €8.36B
P/E 23.0
Fwd P/E 17.4
Weight 3.05%
Market Cap €6.48B
P/E -
Fwd P/E -27.8
Weight 2.8%
Market Cap €4.61B
P/E -
Fwd P/E -15.2
Weight 2.55%
Market Cap €3.25B
P/E 32.3
Fwd P/E 23.2
Weight 2.35%
Market Cap €7.49B
P/E 17.6
Fwd P/E 80.5
Weight 2.2%
Market Cap €3.23B
P/E -
Fwd P/E 17.7
Weight 1.86%
Market Cap €938.15B
P/E 39.3
Fwd P/E 24.8
Weight 1.85%
Market Cap €2.94B
P/E 30.6
Fwd P/E 49.4
Weight 1.79%
Market Cap €2.37B
P/E -
Fwd P/E -5.4
Weight 1.76%
Market Cap €1.79B
P/E -
Fwd P/E 56.2
Weight 1.68%
Market Cap €167.29B
P/E -
Fwd P/E 15.2
Weight 1.64%
Market Cap €1.68B
P/E -
Fwd P/E 7.4
Results 1 - 25 of 50
Per page:
Page 1 / 2